Novel 660 300 mg (Trimethobenzamide hydrochloride 300 mg)
Pill imprint Novel 660 300 mg has been identified as Trimethobenzamide hydrochloride 300 mg.
Trimethobenzamide is used in the treatment of nausea/vomiting and belongs to the drug class anticholinergic antiemetics. FDA has not classified the drug for risk during pregnancy. Trimethobenzamide 300 mg is classified as a Schedule N controlled substance under the Controlled Substance Act (CSA).
- 300 mg
- Prescription only
D&C Red No. 28
FD&C Blue No. 1
FD&C Red No. 40
ethylene glycol monoethyl ether
More about trimethobenzamide
- Trimethobenzamide solution
- Trimethobenzamide (Advanced Reading)
- Trimethobenzamide Intramuscular (Advanced Reading)
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2015 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.